丙型肝炎病毒感染的老年患者。
Hepatitis C Virus Infection in the Older Patient.
机构信息
Department of Medicine, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA 94122, USA.
Department of Medicine, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA 94122, USA; Medical Service, Department of Veteran Affairs Medical Center, San Francisco, CA 94121, USA.
出版信息
Infect Dis Clin North Am. 2017 Dec;31(4):827-838. doi: 10.1016/j.idc.2017.07.014.
Abstract
Hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is of concern in older adults. HCV infection is associated with not only hepatic but also extrahepatic comorbidities common to the aging patient including diabetes, kidney and cardiovascular diseases, and neurocognitive impairment. The effect of direct-acting antiviral agents to treat HCV on these outcomes is limited. This article summarizes the literature regarding the epidemiology and natural history of HCV infection; the impact of age on clinical outcomes in HCV-infected persons; and current knowledge regarding safety and efficacy of HCV treatment regimens in the older patient.
摘要
丙型肝炎病毒（HCV）是美国最常见的血源感染病毒，也是老年人关注的问题。HCV 感染不仅与肝脏有关，还与老年患者常见的肝外合并症有关，包括糖尿病、肾脏和心血管疾病以及神经认知障碍。直接作用抗病毒药物治疗 HCV 对这些结果的影响是有限的。本文总结了关于 HCV 感染的流行病学和自然史的文献；年龄对 HCV 感染患者临床结局的影响；以及关于老年患者 HCV 治疗方案的安全性和疗效的现有知识。
相似文献
1
Hepatitis C Virus Infection in the Older Patient.丙型肝炎病毒感染的老年患者。
Infect Dis Clin North Am. 2017 Dec;31(4):827-838. doi: 10.1016/j.idc.2017.07.014.
2
The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.终结丙型肝炎病毒之路的开端：第 26 届丙型肝炎病毒及相关病毒国际研讨会综述。
Viruses. 2020 Mar 11;12(3):302. doi: 10.3390/v12030302.
3
What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?直接作用抗病毒药物治疗丙型肝炎病毒感染的持续病毒学应答有哪些益处？
Gastroenterology. 2019 Jan;156(2):446-460.e2. doi: 10.1053/j.gastro.2018.10.033. Epub 2018 Oct 24.
4
Current status of hepatitis C virus infection in Korea.韩国丙型肝炎病毒感染的现状。
Intervirology. 2006;49(1-2):70-5. doi: 10.1159/000087266.
5
Hepatitis C: A New Era.丙型肝炎：一个新时代。
Prim Care. 2017 Dec;44(4):631-642. doi: 10.1016/j.pop.2017.07.006. Epub 2017 Oct 5.
6
HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.与男性发生性行为的艾滋病毒呈阳性者在急性丙型肝炎发作后发生显著肝纤维化的风险很高。
J Viral Hepat. 2017 Oct;24(10):832-839. doi: 10.1111/jvh.12707. Epub 2017 Apr 25.
7
Impact of hepatitis C virus treatment on the risk of non-hepatic cancers among hepatitis C virus-infected patients in the US.美国丙型肝炎病毒感染者接受丙型肝炎病毒治疗对非肝脏癌症风险的影响。
Aliment Pharmacol Ther. 2020 Nov;52(10):1592-1602. doi: 10.1111/apt.16081. Epub 2020 Sep 15.
8
New Antiviral Agents for Treatment of Hepatitis C.用于治疗丙型肝炎的新型抗病毒药物
Clin Obstet Gynecol. 2019 Dec;62(4):823-834. doi: 10.1097/GRF.0000000000000457.
9
Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.丙型肝炎：从炎症发病机制到抗炎/肝保护治疗。
World J Gastroenterol. 2018 Dec 21;24(47):5297-5311. doi: 10.3748/wjg.v24.i47.5297.
10
Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.丙型肝炎病毒相关并发症在女性退伍军人中日益增多：一项全国队列研究。
J Viral Hepat. 2017 Nov;24(11):955-965. doi: 10.1111/jvh.12728. Epub 2017 Aug 16.
引用本文的文献
1
Sustained virological response in HCV patients receiving antiviral treatment at a teaching centre of northern India.在印度北部一个教学中心接受抗病毒治疗的丙肝患者的持续病毒学应答
J Family Med Prim Care. 2025 Mar;14(3):942-946. doi: 10.4103/jfmpc.jfmpc_1379_24. Epub 2025 Mar 25.
2
Detection of H-Pylori in the Explanted Liver Tissue and the Enlarged Perihepatic Lymph Nodes of Cirrhotic Patients with Decompensated End-Stage Liver Disease Recruited for Liver Transplantation.对因终末期失代偿性肝病而接受肝移植的肝硬化患者的移植肝组织及肝周肿大淋巴结中幽门螺杆菌的检测
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):181-187. doi: 10.31557/APJCP.2025.26.1.181.
3
Curing of chronic hepatitis C combined with coronavirus disease 2019 in a couple over 85 years old: a case series study.一对85岁以上夫妇慢性丙型肝炎合并2019冠状病毒病的治愈情况：一项病例系列研究
Front Microbiol. 2024 Jul 31;15:1438827. doi: 10.3389/fmicb.2024.1438827. eCollection 2024.
4
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.丙型肝炎病毒的当代见解：全面综述
Microorganisms. 2024 May 21;12(6):1035. doi: 10.3390/microorganisms12061035.
5
Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs.在减少样本量的同时提高疫苗临床试验的公平性：一种基于机器学习的招募方法及其在改善注射吸毒者丙型肝炎病毒疫苗试验中的应用
Healthcare (Basel). 2024 Mar 13;12(6):644. doi: 10.3390/healthcare12060644.
6
Hepatitis C Virus Infection and Hospital-Related Outcomes: A Systematic Review.丙型肝炎病毒感染与医院相关结局：系统评价。
Can J Gastroenterol Hepatol. 2024 Mar 7;2024:3325609. doi: 10.1155/2024/3325609. eCollection 2024.
7
Chronic Liver Disease in the Older Patient-Evaluation and Management.老年患者的慢性肝病——评估与管理。
Curr Gastroenterol Rep. 2023 Dec;25(12):390-400. doi: 10.1007/s11894-023-00908-2. Epub 2023 Nov 22.
8
Cognitive Performance in Asymptomatic Elderly People with Hepatitis C: The Role of Education.丙型肝炎无症状老年人的认知表现：教育的作用。
J Clin Med. 2023 Jul 10;12(14):4588. doi: 10.3390/jcm12144588.
9
Seroprevalence and trends of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in Syrian blood donors at Damascus University Blood Center between 2004 and 2021.2004 年至 2021 年期间，叙利亚大马士革大学血液中心的叙利亚献血者中乙型肝炎病毒、丙型肝炎病毒和人类免疫缺陷病毒的血清流行率和趋势。
Front Public Health. 2023 Jun 1;11:1174638. doi: 10.3389/fpubh.2023.1174638. eCollection 2023.
10
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study.Glecaprevir/Pibrentasvir 治疗 8 周在挑战性 HCV 患者中的安全性和有效性：来自 CREST 研究的意大利数据。
PLoS One. 2023 Feb 2;18(2):e0280165. doi: 10.1371/journal.pone.0280165. eCollection 2023.
本文引用的文献
1
Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients.直接作用抗病毒药物对老年慢性丙型肝炎患者治疗有效：一项纳入17487例患者的真实世界研究
Eur J Gastroenterol Hepatol. 2017 Jun;29(6):686-693. doi: 10.1097/MEG.0000000000000858.
2
Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study.美国老年成年人丙型肝炎病毒感染与癌症风险：一项基于登记处的病例对照研究。
Cancer. 2017 Apr 1;123(7):1202-1211. doi: 10.1002/cncr.30559. Epub 2017 Jan 24.
3
Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.索非布韦、来迪帕司韦/索非布韦、或帕利瑞韦/利托那韦/奥比他韦与达沙布韦治疗方案在退伍军人事务部国家医疗保健系统中治疗丙型肝炎患者的有效性。
Gastroenterology. 2016 Sep;151(3):457-471.e5. doi: 10.1053/j.gastro.2016.05.049. Epub 2016 Jun 4.
4
Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.美国老年退伍军人丙型肝炎感染的流行病学及转归
J Viral Hepat. 2016 Sep;23(9):687-96. doi: 10.1111/jvh.12533. Epub 2016 Apr 3.
5
Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.丙型肝炎病毒感染退伍军人持续病毒学应答后发生肝细胞癌的风险
Hepatology. 2016 Jul;64(1):130-7. doi: 10.1002/hep.28535. Epub 2016 Apr 19.
6
Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis.长期护理机构中老年丙型肝炎病毒感染负担：文献系统评价与荟萃分析
Curr Infect Dis Rep. 2016 Mar;18(4):13. doi: 10.1007/s11908-016-0518-9.
7
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older.来迪派韦索磷布韦治疗 65 岁及以上基因 1 型丙型肝炎病毒感染受试者的安全性和疗效。
Hepatology. 2016 Apr;63(4):1112-9. doi: 10.1002/hep.28425. Epub 2016 Feb 22.
8
A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染患者慢性肾脏病风险的荟萃分析评估
J Viral Hepat. 2015 Nov;22(11):897-905. doi: 10.1111/jvh.12413. Epub 2015 Apr 22.
9
Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease.慢性丙型肝炎疾病中缺乏 CD127 的迟发性衰老 T 细胞的频率增加。
Eur J Clin Invest. 2015 May;45(5):466-74. doi: 10.1111/eci.12429. Epub 2015 Mar 16.
10
Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.美国一大群退伍军人中丙型肝炎病毒感染与慢性肾脏病发病率及进展的关联
Hepatology. 2015 May;61(5):1495-502. doi: 10.1002/hep.27664. Epub 2015 Mar 20.
Zotero 插件